Skip to main content
Premium Trial:

Request an Annual Quote

Cellectis Bioresearch Receives Second NIH Contract for $6.9M

NEW YORK (GenomeWeb News) – Cellectis bioresearch said today it has been awarded a second contract to provide services to the National Institutes of Health and other certain government agencies.

The multiple award, indefinite deliver/indefinite quantity contract, worth up to $6.9 million over three years, follows last week's announced $9.5 million contract with NIH. Under its terms, Cellectis bioresearch, a subsidiary of the Cellectis Group, will generate induced pluripotent stem cell lines of research grade and differentiate iPS cells toward specific tissue cell type for research use.

Based in Paris, Cellectis bioresearch provides genome customization tools and services and develops genetically customized cells adapted for drug discovery, gene function research, and protein production.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.